Clinical Trial Update: Isoniazid (INH) Treatment Based on ELISPOT Assay [NA]

View source ↗

Summary

Clinical trial evaluating isoniazid treatment guided by ELISPOT assay in kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Asan Medical Center | Conditions: Kidney Transplant Recipient | NA | Status: COMPLETED